Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2) (N-Term) Peptid

PRKAB2 Reaktivität: Human, Ratte Wirt: Synthetic BP, WB
Produktnummer ABIN982205

Kurzübersicht für Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2) (N-Term) Peptid (ABIN982205)

Target

PRKAB2 (Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2))

Spezies

Human, Ratte

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequenz

    HKIMVGSTDD PSVFSLPDSK LPGDKEFVPW QQDLDDSVKP TQQARPTVIR

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-Prkab2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PRKAB2 (Protein Kinase, AMP-Activated, beta 2 Non-Catalytic Subunit (PRKAB2))

    Hintergrund

    Prkab2 is a component of the AMPK alpha2beta2gamma1 complex which phosphorylates glycogen synthase.

    Alias Symbols: MGC93432

    Protein Size: 271

    Molekulargewicht

    29 kDa

    Gen-ID

    64562

    NCBI Accession

    NM_022627, NP_072149

    UniProt

    Q9QZH4
Sie sind hier:
Chat with us!